MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 02.03.2026
uniQure N.V. EV 2011-2026 | QURE
EV Jährlich uniQure N.V.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.17 B | 992 M | 704 M | 979 M | 487 M | 1.43 B | 2.12 B | 1.04 B | 487 M | 132 M | 315 M | 424 M | 46.1 M | 7.95 M | 10.9 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 2.12 B | 7.95 M | 689 M |
EV anderer Aktien in der Pharmaeinzelhändler
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
1.82 B | - | 2.43 % | $ 254 M |  Germany |
 |
Acorda Therapeutics
ACOR
|
-13.2 M | - | -24.86 % | $ 820 K |  USA |
 |
ACADIA Pharmaceuticals
ACAD
|
3.33 B | $ 22.42 | 1.49 % | $ 3.72 B | USA |
 |
Adverum Biotechnologies
ADVM
|
125 M | - | - | $ 86.2 M | USA |
 |
AlloVir
ALVR
|
-55.1 M | - | 4.14 % | $ 49.1 M | USA |
 |
Applied Molecular Transport
AMTI
|
7.6 M | - | - | $ 10.1 M | USA |
 |
Applied Therapeutics
APLT
|
563 M | - | - | $ 8.42 M | USA |
 |
I-Mab
IMAB
|
8.28 B | - | - | $ 866 M |  China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
1.95 B | - | - | $ 40.3 B | USA |
 |
Genfit SA
GNFT
|
168 B | - | 2.54 % | $ 160 B |  France |
 |
Alnylam Pharmaceuticals
ALNY
|
43.3 B | $ 326.77 | 2.27 % | $ 42.8 B | USA |
 |
Biophytis SA
BPTS
|
525 M | - | -13.47 % | $ 169 M | France |
 |
Amgen
AMGN
|
189 B | $ 349.41 | 2.77 % | $ 188 B | USA |
 |
AVROBIO
AVRO
|
-35.4 M | - | 1083.1 % | $ 745 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
5.32 M | - | - | $ 7.46 M |  Israel |
 |
AstraZeneca PLC
AZN
|
59.6 B | - | - | $ 96.9 B |  Britain |
 |
Midatech Pharma plc
MTP
|
4.79 M | - | -18.52 % | $ 27.3 M | Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
3.41 B | - | -1.52 % | $ 24.7 M | USA |
 |
BeiGene, Ltd.
BGNE
|
-720 M | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Alterity Therapeutics Limited
ATHE
|
-28.9 M | $ 3.85 | 2.39 % | $ 9.26 B |  Australia |
 |
CymaBay Therapeutics
CBAY
|
3.36 B | - | - | $ 3.45 B | USA |
 |
Advaxis
ADXS
|
-3.02 M | - | -9.65 % | $ 45.9 M | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
1.92 B | $ 20.33 | -1.21 % | $ 950 M | USA |
 |
Aquestive Therapeutics
AQST
|
540 M | $ 4.16 | 0.73 % | $ 445 M | USA |
 |
Avid Bioservices
CDMO
|
661 M | - | - | $ 789 M | USA |
 |
Cidara Therapeutics
CDTX
|
9.99 M | - | - | $ 1.41 B | USA |
 |
Arcutis Biotherapeutics
ARQT
|
3.64 B | $ 24.49 | 5.24 % | $ 3.12 B | USA |
 |
Институт стволовых клеток человека
ISKJ
|
14.1 M | - | - | - |  Russia |
 |
Cabaletta Bio
CABA
|
253 M | $ 3.07 | -0.16 % | $ 308 M | USA |
 |
Checkpoint Therapeutics
CKPT
|
174 M | - | - | $ 169 M | USA |
 |
Aeterna Zentaris
AEZS
|
5.52 M | - | 5.93 % | $ 314 M |  Canada |
 |
Checkmate Pharmaceuticals
CMPI
|
11.4 M | - | - | $ 231 M | USA |
 |
AgeX Therapeutics
AGE
|
3.93 M | - | -10.17 % | $ 12.2 K | USA |
 |
Concert Pharmaceuticals
CNCE
|
14.7 M | - | - | $ 401 M | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-23.2 M | - | - | $ 1.01 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
-9.16 M | - | - | $ 26.5 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
629 M | $ 1.48 | 8.46 % | $ 394 M | Britain |
 |
CTI BioPharma Corp.
CTIC
|
664 M | - | - | $ 1.2 B | USA |
 |
AIkido Pharma
AIKI
|
9.53 M | - | 1.93 % | $ 17.4 M | USA |
 |
Aptose Biosciences
APTO
|
36.2 M | - | -45.71 % | $ 1.2 M | Canada |
 |
Cyclacel Pharmaceuticals
CYCCP
|
-2.16 M | - | -4.36 % | $ 27 M | USA |
 |
Deciphera Pharmaceuticals
DCPH
|
1.24 B | - | - | $ 2.18 B | USA |
 |
Aytu BioScience
AYTU
|
-15.2 M | $ 2.71 | 5.51 % | $ 17 M | USA |
 |
Akero Therapeutics
AKRO
|
2.99 B | - | - | $ 3.67 B | USA |
 |
Dynavax Technologies Corporation
DVAX
|
2.02 B | - | - | $ 2.02 B | USA |
 |
CureVac N.V.
CVAC
|
3.19 B | - | - | $ 867 M | Germany |
 |
Akari Therapeutics, Plc
AKTX
|
79.3 B | $ 3.75 | -1.32 % | $ 252 B | Britain |
 |
Akouos
AKUS
|
95.1 M | - | 0.23 % | $ 488 M | USA |
 |
Allakos
ALLK
|
122 M | - | - | $ 28.6 M | USA |
 |
Allena Pharmaceuticals
ALNA
|
-14.1 M | - | 3.16 % | $ 1.9 M | USA |